AZP-3601

· Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZP-3601, covering 2024-01-31 to 2024-01-31. Get the full timeline:

Most recent: Clinical Trial Update: AZP-3601 SAD and MAD Study in Healthy Subjects and Patients With Hypoparathyroidism [Phase 1, Phase 2]